Faculty of Pharmaceutical Sciences is where great minds make a difference. The Faculty enjoys an international reputation for outstanding pharmaceutical sciences research. Across a broad base of collaborative, paradigm-shaping pilot projects, our world-leading researchers generate relevant results that address the pressing health needs of society. In short, our work improves lives.

If you are passionate about health sciences research that makes a difference in people's lives, you're in good hands. We offer award-wining graduate programs led by world-class researchers. You'll have access to top-tier facilities and be working alongside the best and brightest in the field, conducting research that addresses real life problems. Our paradigm-changing approach is collaborative, innovative, and results-driven.

We're tackling diseases like asthma / chronic obstructive pulmonary disease, diabetes, cancer, heart disease, and arthritis. We're developing better ways to deliver drugs and prevent adverse drug reactions. And we're conducting clinical and economic research in pharmaceutical outcomes. 

Our reputation as a top research centre attracts some of the brightest and most productive minds in the field. Our faculty includes Canada Research Chairs, Michael Smith Foundation for Health Research Scholars and Senior Scholars, and Distinguished University Scholars.

Purpose

We are innovators in pharmacy education, research and practice, with the goal of supporting the optimization of drug therapy in the pursuit of improved patient outcomes.

Commitments

  • We support our people, creating a community that enables excellence through collective action.
  • We seek novel ideas, putting into practice those with the greatest scope for sustained impact.
  • We search for relevant connections, fostering meaningful collaborations that provide mutual benefit.
Mission
To be a catalyst for change in pharmacy practice and the pharmaceutical sciences.
 

Research Centres

adMare BioInnovations is located in our building. It is an independent, non-profit organization with a focus on bridging the gap between academic discoveries in the health sciences and the development of new medicines to treat human disease. The Faculty partners with adMare BioInnovations to provide unique research and mentoring opportunities for MSc and PhD students. 

We are also home to several sophisticated research centres that specialize in the areas of human genome and exome sequencing, and health outcomes research.

Research Facilities

Opened in 2012, the Pharmaceutical Sciences Building at UBC is a state-of-the-art learning and research facility. The building houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities are fitted with advanced technology to facilitate new modes of learning.

Measuring 246,000 square feet, it's an eye-catching addition to our campus, and has drawn attention and admiration from around the world—including 15 awards of excellence. 

Research Highlights

As a leading research faculty, we conduct ground-breaking research in the pharmaceutical sciences – all with the goal of addressing the pressing health needs of society and improving lives. Our research activities centre around four areas of focus.

Epidemiology & Health Outcomes

This theme covers our activities in epidemiological analysis, health outcomes and health economics research seeking solutions for the predictive enhancement of intervention strategies for practical and preventive healthcare. The impact of this work is used to shape policy to optimize the allocation of health care resources as well as defining the efficacy of healthcare interventions and strategy.

Molecular & Systems Pharmacology

This highly interdisciplinary theme embodies research directed at the interactions of therapeutic agents with human cells, and covers fundamental questions of the mechanisms of the drug action through to the behaviour of drugs in human systems. These studies are used to inform and optimize the development and delivery of drug intervention regimes for clinical practice and the pharmaceutical industry.

Nanomedicine & Chemical Biology

This theme applies our expertise in the chemical biology of the fabrication and handling of nanoscopic materials to drug discovery and delivery. Sensing and screening technologies are also an important focus.

Pharmacy Education

Our research in this theme addresses the issue of scholarship in pharmacy and the pharmaceutical sciences with a view to augment our educational research capacity and enhance the methodologies of teaching practice, student learning and curriculum decision-making.

Explore Research Themes

Graduate Degree Programs

Research Supervisors in Faculty

Name Research Interests
Burt, Helen Mary Nanotechnology, non-sized drug carriers, nanoparticulte drug delivery
Cairns, Brian Neurosciences, biological and chemical aspects; Neurosciences, medical and physiological and health aspects; Pharmacology and pharmaceutical sciences (except clinical aspects); electrophysiology; headache; Neuropharmacology; Oro-Facial Pain; pain; pain mechanisms; peripheral analgesics; sex-related differences; temporomandibular disorders
Chang, Thomas Pharmacology and pharmaceutical sciences (except clinical aspects); Drug Metabolism; Cytochrome P450; Drug-Metabolizing Enzymes; Gene Expression; Gene regulation; Nuclear Receptor; Pharmacology
Collier, Abby Drugs in children, Drugs in pregnancy, Developmental pharmacology, Drug metabolism, Pharmacokinetics, Drug metabolism and pharmacokinetics, primarily of the phase II (conjugation) enzymes, focused on pregnancy and pediatrics
Conklin, Annalijn Human nutrition and dietetics; Pharmacology and pharmaceutical sciences (except clinical aspects); Chronic Diseases in Elderly; Community Health / Public Health; disease management evaluation; food and nutrition policy; Gender Epidemiology; gender and health equity; Health Policies; healthcare quality improvement; healthy ageing; Indigenous health; Obesity; obesity & CVD risk factors; Professional Practices; Social Determinants of Dietary and Metabolic Disorders; social nutritional epidemiology
Coughtrie, Michael Drug metabolizing enzymes
Cragg, Jacquelyn Epidemiology (except nutritional and veterinary epidemiology); data science; open science; Causal inference; Drug Effectiveness; Drug Safety; Epidemiology; neuro-epidemiology; Neurological diseases; Spinal cord injury; Amyotrophic Lateral Sclerosis (ALS); multiple sclerosis; Parkinson’s disease
De Vera, Mary examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions.
Frankel, Adam Pharmacology and pharmaceutical sciences (except clinical aspects); Biological and Biochemical Mechanisms; Bioactive Molecules; Organic Molecules and Biomolecules; Proteins; arginine methylation; autophagy; Chemical Biology; drug discovery; post-translational modifications; Protein Biochemistry; yeast
Giaever, Guri Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation
Hafeli, Urs Pharmacokinetics; Imaging; Radiotherapy; Immunotherapy; Development of Drug Delivery Systems; Radiopharmaceuticals; Radioimmunotherapy; Magnetic Targeting; Targeted Drug Delivery; Novel polymers; Nanoparticles; Microspheres; Microneedles; Bioconjugates
Harrison, Mark measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered
Hedtrich, Sarah Pharmacology and pharmaceutical sciences (except clinical aspects); Nanotechnologies; Structural Tissue Engineering / Biomaterials; Inflammatory Respiratory Diseases; Skin; New Biomedical Approaches - Alternatives to Animal Testing; Novel therapies for inflammatory and genetic diseases of human epithelia; Tissue Regeneration and Wound Healing; Topical drug delivery and Nanomedicine
Jarvis-Selinger, Sandra Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology
Kumar, Ujendra Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs
Lalji, Fawziah Pharmacology and pharmaceutical sciences (except clinical aspects); Pharmacoepidemiology; Infectious diseases; Vaccination; Antibiotics and Resistance; Tuberculosis
Lau, Tim ,
Li, Shyh-Dar Pharmacology and pharmaceutical sciences (except clinical aspects); biopharmaceutics; drug delivery; nanomedicine; pharmaceutics
Loewen, Peter Pharmacology and pharmaceutical sciences (except clinical aspects); Cardiovascular diseases; Arrhythmia; Thrombosis and Embolism; Heart Failure; Pharmacoepidemiology; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; adherence to medication; atrial fibrillation; clinical prediction rules; healthcare communication technologies; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making
Lynd, Larry health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases
Maharaj, Anil Pharmacology and pharmaceutical sciences, n.e.c.; Pharmacometrics; Pharmacokinetics/Pharmacodynamics; Obstetric and Pediatric Pharmacology
McCormack, James Knowledge translation and evidence-based practice
Nislow, Corey genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing
Page, Brent Pharmacology and pharmaceutical sciences (except clinical aspects); Cell Signaling and Cancer; Cancer; Cell signaling; Chemical Biology; Drug development; drug discovery; Medicinal Chemistry; Target Engagement
Rodrigues, Brian Pharmacology and pharmaceutical sciences (except clinical aspects); Diabetes; Cardiomyopathy; Heart Failure; Energy Metabolism; Cardiovascular metabolism; Endothelial cell - cardiomyocyte crosstalk; Vascular Endothelial Growth factors

Pages

Open Research Positions

This list of possible research projects is non-exhaustive. It only shows positions that are specifically advertised in the G+PS website.

Graduate Student Stories

Petar Iliev

Doctor of Philosophy in Pharmaceutical Sciences (PhD)

Developing selective small-molecule probes for STAT3 using thermal stability assays

Michael Rowley

Doctor of Philosophy in Pharmaceutical Sciences (PhD)

Development of small-molecule inhibitors against Protein Arginine N-methyltransferase 2

Yuejian Liu

Doctor of Philosophy in Pharmaceutical Sciences (PhD)

Structure-function relationships of uridine diphosphate glucuronosyltransferases

Danielle Hanke

Master of Science in Pharmaceutical Sciences (MSc)

Medicinal Chemistry

Arwa Nemir

Master of Science in Pharmaceutical Sciences (MSc)

Exploring What Patients Can Teach Us About Pharmacy Student Skills

Tarique Benbow

Doctor of Philosophy in Pharmaceutical Sciences (PhD)

The CB2 receptor as a potential target for Vascular Headaches

Sumreen Javed

Doctor of Philosophy in Pharmaceutical Sciences (PhD)

Understanding Role of Invadopodia in Breast Tumor metastasis via Lymphatics.

Jennifer Brown

Doctor of Philosophy in Pharmaceutical Sciences (PhD)

Identification and elucidation of the roles of methylarginine-containing proteins in stress and aging in Saccharomyces cerevisiae
All Student Stories

Alumni on Success

Swamy Yeleswaram

Doctor of Philosophy in Pharmaceutical Sciences (PhD) [1992]

Job Title
VP

Employer
Incyte Corporation

Gary Lopaschuk

Doctor of Philosophy in Pharmaceutical Sciences (PhD) [1983]

Job Title
Professor

Employer
University of Alberta
All Alumni Stories

Recent Publications

This is an incomplete sample of recent publications in chronological order by UBC faculty members with a primary appointment in the Faculty of Pharmaceutical Sciences.

 

Altering the intra-liver distribution of phospholipid-free small unilamellar vesicles using temperature-dependent size-tunability
Publication: Journal of Controlled Release
UBC Author(s): Shyh-Dar Li (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 01683659
Volume: 333
Page Range: 151-161
Publication Date: 10 May 2021

View Publication
Preface to the Special Issue “Scientific and Clinical Applications of Magnetic Carriers”
Publication: Journal of Magnetism and Magnetic Materials
UBC Author(s): Urs Hafeli (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 03048853
Volume: 525
Publication Date: 1 May 2021

View Publication
Social connections and hypertension in women and men: a population-based cross-sectional study of the Canadian Longitudinal Study on Aging
Publication: Journal of hypertension
UBC Author(s): Annalijn Conklin (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 39
Page Range: 651-660
Publication Date: 1 April 2021

View Publication
Topical diclofenac vs placebo for the treatment of chronic Achilles tendinopathy: A randomized controlled clinical trial
Publication: PLoS ONE
UBC Author(s): Brian Cairns (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 16
Publication Date: March 2021

View Publication
Novel Neurotechnological Interventions for Pediatric Drug-Resistant Epilepsy: Physician Perspectives
Publication: Journal of Child Neurology
UBC Author(s): Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 08830738
Volume: 36
Page Range: 222-229
Publication Date: March 2021

View Publication
Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD
Publication: Applied Health Economics and Health Policy
UBC Author(s): Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Larry Lynd (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Mohsen Sadatsafavi (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 11755652
Volume: 19
Page Range: 203-215
Publication Date: March 2021

View Publication
Population pharmacokinetics of olanzapine in children
Publication: British Journal of Clinical Pharmacology
UBC Author(s): Anil Maharaj (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 03065251
Volume: 87
Page Range: 542-554
Publication Date: February 2021

View Publication
On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion
Publication: Nuclear Medicine and Biology
UBC Author(s): Urs Hafeli (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 09698051
Volume: 93
Page Range: 19-21
Publication Date: February 2021

View Publication
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
Publication: European Respiratory Journal
UBC Author(s): Mohsen Sadatsafavi (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 09031936
Volume: 57
Publication Date: 1 February 2021

View Publication
Independent Registries Are Cost-Effective Tools to Provide Mandatory Postauthorization Surveillance for Orphan Medicinal Products
Publication: Value in Health
UBC Author(s): Larry Lynd (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 10983015
Volume: 24
Page Range: 268-273
Publication Date: February 2021

View Publication
Preventable adverse drug events causing hospitalisation: Identifying root causes and developing a surveillance and learning system at an urban community hospital, a cross-sectional observational study
Publication: BMJ Open Quality
UBC Author(s): Peter Shane Loewen (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Peter Zed (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 10
Publication Date: 25 January 2021

View Publication
Virtual Oncology Appointments during the Initial Wave of the COVID-19 Pandemic: An International Survey of Patient Perspectives
Publication: Current oncology (Toronto, Ont.)
UBC Author(s): Mary De Vera (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 28
Page Range: 671-677
Publication Date: 22 January 2021

View Publication
Nanoscale flow cytometry for immunophenotyping and quantitating extracellular vesicles in blood plasma
Publication: Nanoscale
UBC Author(s): Karla Williams (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 20403364
Volume: 13
Page Range: 2012-2025
Publication Date: 21 January 2021

View Publication
Rapid Implementation of Model-Based Dosing Recommendations during the Coronavirus Disease 2019 Pandemic - Reply
Publication: JAMA Pediatrics
UBC Author(s): Anil Maharaj (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 21686203
Publication Date: 2021

View Publication
Use of Preventive Medications in Patients With Nonobstructive Coronary Artery Disease: Analysis of the PROMISE Trial
Publication: CJC Open
UBC Author(s): Ricky Turgeon (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Publication Date: 2021

View Publication
The design, characterization and antibacterial activity of heat and silver crosslinked poly(Vinyl alcohol) hydrogel forming dressings containing silver nanoparticles
Publication: Nanomaterials
UBC Author(s): Helen Mary Burt (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 11
Page Range: 1-19
Publication Date: January 2021

View Publication
Density of nerve fibres and expression of substance P, NR2B-receptors and nerve growth factor in healthy human masseter muscle: An immunohistochemical study
Publication: Journal of Oral Rehabilitation
UBC Author(s): Brian Cairns (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 0305182X
Volume: 48
Page Range: 35-44
Publication Date: January 2021

View Publication
TSLP as druggable target – a silver-lining for atopic diseases?
Publication: Pharmacology and Therapeutics
UBC Author(s): Sarah Hedtrich (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Brent Page (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 01637258
Volume: 217
Publication Date: January 2021

View Publication
Patient-provider communication about medication cost in rheumatoid arthritis
Publication: Clinical Rheumatology
UBC Author(s): Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 07703198
Volume: 40
Page Range: 93-100
Publication Date: January 2021

View Publication
Somatostatin ameliorates β-amyloid-induced cytotoxicity via the regulation of CRMP2 phosphorylation and calcium homeostasis in SH-SY5Y cells
Publication: Biomedicines
UBC Author(s): Ujendra Kumar (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 9
Page Range: 1-18
Publication Date: January 2021

View Publication
Utilization of telehealth in paediatric genome-wide sequencing: Health services implementation issues in the CAUSES Study
Publication: Journal of Telemedicine and Telecare
UBC Author(s): Larry Lynd (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 1357633X
Publication Date: 2021

View Publication
Development of a pharmacist-led internal medicine outpatient consult service
Publication: Canadian Pharmacists Journal
UBC Author(s): Ricky Turgeon (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 17151635
Publication Date: 2021

View Publication
Pharmacotherapy for heart failure with reduced ejection fraction and health-related quality of life: a systematic review and meta-analysis
Publication: European Journal of Heart Failure
UBC Author(s): Ricky Turgeon (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 13889842
Publication Date: 2021

View Publication
The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines
Publication: Expert Opinion on Drug Safety
UBC Author(s): Jacquelyn Cragg (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Mary De Vera (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Larry Lynd (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences), Mohsen Sadatsafavi (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 14740338
Volume: 20
Page Range: 1-8
Publication Date: 2021

View Publication
PEER simplified decision aid: chronic back pain treatment options in primary care
Publication: Canadian family physician Medecin de famille canadien
UBC Author(s): James McCormack (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 67
Page Range: 31-34
Publication Date: 1 January 2021

View Publication

Pages

Recent Thesis Submissions

Doctoral Citations

A doctoral citation summarizes the nature of the independent research, provides a high-level overview of the study, states the significance of the work and says who will benefit from the findings in clear, non-specialized language, so that members of a lay audience will understand it.
Year Citation Program
2020 Dr. Lin performed structure-activity relationship studies on anti-HIV molecules. During this process, she discovered novel chemical reactivities of these compounds. The findings are crucial for the future development of biologically active molecules toward treatments of various diseases and crop protection. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2020 Dr. Agnoletti investigated the use of polymeric microspheres as carriers to deliver antibiotics selectively to the lungs after intravenous administration. Her findings support the passive lung targeting strategy to improve the treatments of bacterial lung infections and, potentially, other lung diseases. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2020 Dr. Lal studied the role of the protein VEGFB in the diabetic heart. He found that this growth factor has the potential to protect against the changes that occur in the heart following diabetes and can lead to heart failure. This research helps in identifying a novel therapeutic target to prevent diabetic heart disease. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2020 Dr. Atiquzzaman revealed the mediating role of NSAIDs in the increased risk of heart diseases among osteoarthritis patients. He also evaluated the cardiovascular safety of various NSAIDs used to treat osteoarthritis. This will help to understand the link between osteoarthritis and heart disease better and improve the safe treatment of this disease. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2020 Dr. Johnson evaluated strategies for improving the diagnosis of chronic obstructive pulmonary disease (COPD). She found that early detection strategies for COPD are cost-effective, and that the risk of COPD should be assessed regularly at primary care visits. Her research can help to reduce the burden of COPD on patients and the healthcare system. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2019 Current HIV treatment can effectively manage infection, but it is not a cure. Hence, there is a need for new kinds of anti-HIV drugs. Dr. Zamiri discovered two anti-HIV molecules active in both wild and drug resistant HIV strains. Her research suggests a mechanism of action different from the current HIV drugs and may inform future therapies. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2019 Dr. Gorrin constructed a model based on his conversations with people with asthma and measured how participants in two asthma studies reported their medication usage. The integration of his findings helped to understand why some people don't take the medication and how to encourage regular medication usage. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2019 Drug discovery can be lengthy, complicated and requires extensive resources. Working in partnership with the pharmacy and chemistry departments, Dr. Koperniku explored access to pharmaceutically relevant small molecules. Her work advances the optimization of pharmaceuticals and informs improved patient care. Her past and future dedication is to serve humanity. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2019 Dr. Wang found out that heparanase, using its properties to promote cell survival, protect the heart cells against multiple stresses frequently seen in patients with ischemia and diabetes-induced heart diseases, in both cell experiments and animal studies. This research could help devise new strategies to combat heart diseases. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2019 Dr. Lambert investigated causes of pain in fibromyalgia and determined that specialized immune cells in the brain may play a critical role. She also created two novel molecules which act on the endocannabinoid system to reduce the pain-causing actions of these immune cells. Her work may form the basis of a new therapeutic strategy for chronic pain. Doctor of Philosophy in Pharmaceutical Sciences (PhD)

Pages

Interesting Links

https://phargsubc.wixsite.com/phargsubc
http://stories.pharmsci.ubc.ca/health-outcomes-research-mark-harrison
http://stories.pharmsci.ubc.ca/research-in-focus-understanding-the-g-quadruplex